Global Isoflurane Market Growth 2025-2031

September 2025 | 103 pages | ID: G4088B6E4D6EN
LP Information

Abstracts

The global Isoflurane market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Isoflurane, sold under the trade name Forane among others, is a general anesthetic?It can be used to start or maintain anesthesia.[1] Often another medication is used to start anesthesia due to airway irritation with isoflurane.It is used by inhalation.Side effects include a decreased ability to breathe (respiratory depression), low blood pressure, and irregular heartbeat. Serious side effects may include malignant hyperthermia and high blood potassium.It should not be used in people with a history of malignant hyperthermia in either themselves or their family members.It is unknown if use during pregnancy is safe for the baby, but use during a cesarean section appears to be safe.Isoflurane is in the halogenated ether family of medication.Isoflurane was approved for medical use in the United States in 1979. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

United States market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Isoflurane players cover Piramal Critical Care(Piramal Group), Halocarbon, Aesica(Consort Medical Group), Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Isoflurane Industry Forecast” looks at past sales and reviews total world Isoflurane sales in 2024, providing a comprehensive analysis by region and market sector of projected Isoflurane sales for 2025 through 2031. With Isoflurane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isoflurane industry.

This Insight Report provides a comprehensive analysis of the global Isoflurane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Isoflurane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Isoflurane market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isoflurane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isoflurane.

This report presents a comprehensive overview, market shares, and growth opportunities of Isoflurane market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Human Series
• Animal Series

Segmentation by Application:

• Hospitals
• Other Medical Institutions

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Piramal Critical Care(Piramal Group)
• Halocarbon
• Aesica(Consort Medical Group)
• Lunan Pharmaceutical Group
• Shandong Keyuan Pharmaceutical Co., Ltd.
• Pfizer
• Indofine Chemical Company, Inc.
• Medicon Lifesciences
• Rewine Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Isoflurane market?
What factors are driving Isoflurane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Isoflurane market opportunities vary by end market size?
How does Isoflurane break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Isoflurane Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Isoflurane by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Isoflurane by Country/Region, 2020, 2024 & 2031
2.2 Isoflurane Segment by Type
  2.2.1 Human Series
  2.2.2 Animal Series
2.3 Isoflurane Sales by Type
  2.3.1 Global Isoflurane Sales Market Share by Type (2020-2025)
  2.3.2 Global Isoflurane Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Isoflurane Sale Price by Type (2020-2025)
2.4 Isoflurane Segment by Application
  2.4.1 Hospitals
  2.4.2 Other Medical Institutions
2.5 Isoflurane Sales by Application
  2.5.1 Global Isoflurane Sale Market Share by Application (2020-2025)
  2.5.2 Global Isoflurane Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Isoflurane Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Isoflurane Breakdown Data by Company
  3.1.1 Global Isoflurane Annual Sales by Company (2020-2025)
  3.1.2 Global Isoflurane Sales Market Share by Company (2020-2025)
3.2 Global Isoflurane Annual Revenue by Company (2020-2025)
  3.2.1 Global Isoflurane Revenue by Company (2020-2025)
  3.2.2 Global Isoflurane Revenue Market Share by Company (2020-2025)
3.3 Global Isoflurane Sale Price by Company
3.4 Key Manufacturers Isoflurane Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Isoflurane Product Location Distribution
  3.4.2 Players Isoflurane Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ISOFLURANE BY GEOGRAPHIC REGION

4.1 World Historic Isoflurane Market Size by Geographic Region (2020-2025)
  4.1.1 Global Isoflurane Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Isoflurane Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Isoflurane Market Size by Country/Region (2020-2025)
  4.2.1 Global Isoflurane Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Isoflurane Annual Revenue by Country/Region (2020-2025)
4.3 Americas Isoflurane Sales Growth
4.4 APAC Isoflurane Sales Growth
4.5 Europe Isoflurane Sales Growth
4.6 Middle East & Africa Isoflurane Sales Growth

5 AMERICAS

5.1 Americas Isoflurane Sales by Country
  5.1.1 Americas Isoflurane Sales by Country (2020-2025)
  5.1.2 Americas Isoflurane Revenue by Country (2020-2025)
5.2 Americas Isoflurane Sales by Type (2020-2025)
5.3 Americas Isoflurane Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Isoflurane Sales by Region
  6.1.1 APAC Isoflurane Sales by Region (2020-2025)
  6.1.2 APAC Isoflurane Revenue by Region (2020-2025)
6.2 APAC Isoflurane Sales by Type (2020-2025)
6.3 APAC Isoflurane Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Isoflurane by Country
  7.1.1 Europe Isoflurane Sales by Country (2020-2025)
  7.1.2 Europe Isoflurane Revenue by Country (2020-2025)
7.2 Europe Isoflurane Sales by Type (2020-2025)
7.3 Europe Isoflurane Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Isoflurane by Country
  8.1.1 Middle East & Africa Isoflurane Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Isoflurane Revenue by Country (2020-2025)
8.2 Middle East & Africa Isoflurane Sales by Type (2020-2025)
8.3 Middle East & Africa Isoflurane Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Isoflurane
10.3 Manufacturing Process Analysis of Isoflurane
10.4 Industry Chain Structure of Isoflurane

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Isoflurane Distributors
11.3 Isoflurane Customer

12 WORLD FORECAST REVIEW FOR ISOFLURANE BY GEOGRAPHIC REGION

12.1 Global Isoflurane Market Size Forecast by Region
  12.1.1 Global Isoflurane Forecast by Region (2026-2031)
  12.1.2 Global Isoflurane Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Isoflurane Forecast by Type (2026-2031)
12.7 Global Isoflurane Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Piramal Critical Care(Piramal Group)
  13.1.1 Piramal Critical Care(Piramal Group) Company Information
  13.1.2 Piramal Critical Care(Piramal Group) Isoflurane Product Portfolios and Specifications
  13.1.3 Piramal Critical Care(Piramal Group) Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Piramal Critical Care(Piramal Group) Main Business Overview
  13.1.5 Piramal Critical Care(Piramal Group) Latest Developments
13.2 Halocarbon
  13.2.1 Halocarbon Company Information
  13.2.2 Halocarbon Isoflurane Product Portfolios and Specifications
  13.2.3 Halocarbon Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Halocarbon Main Business Overview
  13.2.5 Halocarbon Latest Developments
13.3 Aesica(Consort Medical Group)
  13.3.1 Aesica(Consort Medical Group) Company Information
  13.3.2 Aesica(Consort Medical Group) Isoflurane Product Portfolios and Specifications
  13.3.3 Aesica(Consort Medical Group) Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Aesica(Consort Medical Group) Main Business Overview
  13.3.5 Aesica(Consort Medical Group) Latest Developments
13.4 Lunan Pharmaceutical Group
  13.4.1 Lunan Pharmaceutical Group Company Information
  13.4.2 Lunan Pharmaceutical Group Isoflurane Product Portfolios and Specifications
  13.4.3 Lunan Pharmaceutical Group Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Lunan Pharmaceutical Group Main Business Overview
  13.4.5 Lunan Pharmaceutical Group Latest Developments
13.5 Shandong Keyuan Pharmaceutical Co., Ltd.
  13.5.1 Shandong Keyuan Pharmaceutical Co., Ltd. Company Information
  13.5.2 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Product Portfolios and Specifications
  13.5.3 Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Shandong Keyuan Pharmaceutical Co., Ltd. Main Business Overview
  13.5.5 Shandong Keyuan Pharmaceutical Co., Ltd. Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer Isoflurane Product Portfolios and Specifications
  13.6.3 Pfizer Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 Indofine Chemical Company, Inc.
  13.7.1 Indofine Chemical Company, Inc. Company Information
  13.7.2 Indofine Chemical Company, Inc. Isoflurane Product Portfolios and Specifications
  13.7.3 Indofine Chemical Company, Inc. Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Indofine Chemical Company, Inc. Main Business Overview
  13.7.5 Indofine Chemical Company, Inc. Latest Developments
13.8 Medicon Lifesciences
  13.8.1 Medicon Lifesciences Company Information
  13.8.2 Medicon Lifesciences Isoflurane Product Portfolios and Specifications
  13.8.3 Medicon Lifesciences Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Medicon Lifesciences Main Business Overview
  13.8.5 Medicon Lifesciences Latest Developments
13.9 Rewine Pharmaceutical
  13.9.1 Rewine Pharmaceutical Company Information
  13.9.2 Rewine Pharmaceutical Isoflurane Product Portfolios and Specifications
  13.9.3 Rewine Pharmaceutical Isoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Rewine Pharmaceutical Main Business Overview
  13.9.5 Rewine Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Isoflurane Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Isoflurane Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Human Series
Table 4. Major Players of Animal Series
Table 5. Global Isoflurane Sales by Type (2020-2025) & (K MT)
Table 6. Global Isoflurane Sales Market Share by Type (2020-2025)
Table 7. Global Isoflurane Revenue by Type (2020-2025) & ($ million)
Table 8. Global Isoflurane Revenue Market Share by Type (2020-2025)
Table 9. Global Isoflurane Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Isoflurane Sale by Application (2020-2025) & (K MT)
Table 11. Global Isoflurane Sale Market Share by Application (2020-2025)
Table 12. Global Isoflurane Revenue by Application (2020-2025) & ($ million)
Table 13. Global Isoflurane Revenue Market Share by Application (2020-2025)
Table 14. Global Isoflurane Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Isoflurane Sales by Company (2020-2025) & (K MT)
Table 16. Global Isoflurane Sales Market Share by Company (2020-2025)
Table 17. Global Isoflurane Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Isoflurane Revenue Market Share by Company (2020-2025)
Table 19. Global Isoflurane Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Isoflurane Producing Area Distribution and Sales Area
Table 21. Players Isoflurane Products Offered
Table 22. Isoflurane Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Isoflurane Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Isoflurane Sales Market Share Geographic Region (2020-2025)
Table 27. Global Isoflurane Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Isoflurane Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Isoflurane Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Isoflurane Sales Market Share by Country/Region (2020-2025)
Table 31. Global Isoflurane Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Isoflurane Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Isoflurane Sales by Country (2020-2025) & (K MT)
Table 34. Americas Isoflurane Sales Market Share by Country (2020-2025)
Table 35. Americas Isoflurane Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Isoflurane Sales by Type (2020-2025) & (K MT)
Table 37. Americas Isoflurane Sales by Application (2020-2025) & (K MT)
Table 38. APAC Isoflurane Sales by Region (2020-2025) & (K MT)
Table 39. APAC Isoflurane Sales Market Share by Region (2020-2025)
Table 40. APAC Isoflurane Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Isoflurane Sales by Type (2020-2025) & (K MT)
Table 42. APAC Isoflurane Sales by Application (2020-2025) & (K MT)
Table 43. Europe Isoflurane Sales by Country (2020-2025) & (K MT)
Table 44. Europe Isoflurane Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Isoflurane Sales by Type (2020-2025) & (K MT)
Table 46. Europe Isoflurane Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Isoflurane Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Isoflurane Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Isoflurane Sales by Type (2020-2025) & (K MT)
Table 50. Middle East & Africa Isoflurane Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Isoflurane
Table 52. Key Market Challenges & Risks of Isoflurane
Table 53. Key Industry Trends of Isoflurane
Table 54. Isoflurane Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Isoflurane Distributors List
Table 57. Isoflurane Customer List
Table 58. Global Isoflurane Sales Forecast by Region (2026-2031) & (K MT)
Table 59. Global Isoflurane Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Isoflurane Sales Forecast by Country (2026-2031) & (K MT)
Table 61. Americas Isoflurane Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Isoflurane Sales Forecast by Region (2026-2031) & (K MT)
Table 63. APAC Isoflurane Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Isoflurane Sales Forecast by Country (2026-2031) & (K MT)
Table 65. Europe Isoflurane Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Isoflurane Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Isoflurane Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Isoflurane Sales Forecast by Type (2026-2031) & (K MT)
Table 69. Global Isoflurane Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Isoflurane Sales Forecast by Application (2026-2031) & (K MT)
Table 71. Global Isoflurane Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Piramal Critical Care(Piramal Group) Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 73. Piramal Critical Care(Piramal Group) Isoflurane Product Portfolios and Specifications
Table 74. Piramal Critical Care(Piramal Group) Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Piramal Critical Care(Piramal Group) Main Business
Table 76. Piramal Critical Care(Piramal Group) Latest Developments
Table 77. Halocarbon Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 78. Halocarbon Isoflurane Product Portfolios and Specifications
Table 79. Halocarbon Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Halocarbon Main Business
Table 81. Halocarbon Latest Developments
Table 82. Aesica(Consort Medical Group) Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 83. Aesica(Consort Medical Group) Isoflurane Product Portfolios and Specifications
Table 84. Aesica(Consort Medical Group) Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Aesica(Consort Medical Group) Main Business
Table 86. Aesica(Consort Medical Group) Latest Developments
Table 87. Lunan Pharmaceutical Group Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 88. Lunan Pharmaceutical Group Isoflurane Product Portfolios and Specifications
Table 89. Lunan Pharmaceutical Group Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Lunan Pharmaceutical Group Main Business
Table 91. Lunan Pharmaceutical Group Latest Developments
Table 92. Shandong Keyuan Pharmaceutical Co., Ltd. Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 93. Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Product Portfolios and Specifications
Table 94. Shandong Keyuan Pharmaceutical Co., Ltd. Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Shandong Keyuan Pharmaceutical Co., Ltd. Main Business
Table 96. Shandong Keyuan Pharmaceutical Co., Ltd. Latest Developments
Table 97. Pfizer Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Isoflurane Product Portfolios and Specifications
Table 99. Pfizer Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
Table 102. Indofine Chemical Company, Inc. Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 103. Indofine Chemical Company, Inc. Isoflurane Product Portfolios and Specifications
Table 104. Indofine Chemical Company, Inc. Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Indofine Chemical Company, Inc. Main Business
Table 106. Indofine Chemical Company, Inc. Latest Developments
Table 107. Medicon Lifesciences Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 108. Medicon Lifesciences Isoflurane Product Portfolios and Specifications
Table 109. Medicon Lifesciences Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Medicon Lifesciences Main Business
Table 111. Medicon Lifesciences Latest Developments
Table 112. Rewine Pharmaceutical Basic Information, Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 113. Rewine Pharmaceutical Isoflurane Product Portfolios and Specifications
Table 114. Rewine Pharmaceutical Isoflurane Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Rewine Pharmaceutical Main Business
Table 116. Rewine Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Isoflurane
Figure 2. Isoflurane Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Isoflurane Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Isoflurane Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Isoflurane Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Isoflurane Sales Market Share by Country/Region (2024)
Figure 10. Isoflurane Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Human Series
Figure 12. Product Picture of Animal Series
Figure 13. Global Isoflurane Sales Market Share by Type in 2025
Figure 14. Global Isoflurane Revenue Market Share by Type (2020-2025)
Figure 15. Isoflurane Consumed in Hospitals
Figure 16. Global Isoflurane Market: Hospitals (2020-2025) & (K MT)
Figure 17. Isoflurane Consumed in Other Medical Institutions
Figure 18. Global Isoflurane Market: Other Medical Institutions (2020-2025) & (K MT)
Figure 19. Global Isoflurane Sale Market Share by Application (2024)
Figure 20. Global Isoflurane Revenue Market Share by Application in 2025
Figure 21. Isoflurane Sales by Company in 2025 (K MT)
Figure 22. Global Isoflurane Sales Market Share by Company in 2025
Figure 23. Isoflurane Revenue by Company in 2025 ($ millions)
Figure 24. Global Isoflurane Revenue Market Share by Company in 2025
Figure 25. Global Isoflurane Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Isoflurane Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Isoflurane Sales 2020-2025 (K MT)
Figure 28. Americas Isoflurane Revenue 2020-2025 ($ millions)
Figure 29. APAC Isoflurane Sales 2020-2025 (K MT)
Figure 30. APAC Isoflurane Revenue 2020-2025 ($ millions)
Figure 31. Europe Isoflurane Sales 2020-2025 (K MT)
Figure 32. Europe Isoflurane Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Isoflurane Sales 2020-2025 (K MT)
Figure 34. Middle East & Africa Isoflurane Revenue 2020-2025 ($ millions)
Figure 35. Americas Isoflurane Sales Market Share by Country in 2025
Figure 36. Americas Isoflurane Revenue Market Share by Country (2020-2025)
Figure 37. Americas Isoflurane Sales Market Share by Type (2020-2025)
Figure 38. Americas Isoflurane Sales Market Share by Application (2020-2025)
Figure 39. United States Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Isoflurane Sales Market Share by Region in 2025
Figure 44. APAC Isoflurane Revenue Market Share by Region (2020-2025)
Figure 45. APAC Isoflurane Sales Market Share by Type (2020-2025)
Figure 46. APAC Isoflurane Sales Market Share by Application (2020-2025)
Figure 47. China Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 51. India Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Isoflurane Sales Market Share by Country in 2025
Figure 55. Europe Isoflurane Revenue Market Share by Country (2020-2025)
Figure 56. Europe Isoflurane Sales Market Share by Type (2020-2025)
Figure 57. Europe Isoflurane Sales Market Share by Application (2020-2025)
Figure 58. Germany Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 59. France Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Isoflurane Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Isoflurane Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Isoflurane Sales Market Share by Application (2020-2025)
Figure 66. Egypt Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Isoflurane Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Isoflurane in 2025
Figure 72. Manufacturing Process Analysis of Isoflurane
Figure 73. Industry Chain Structure of Isoflurane
Figure 74. Channels of Distribution
Figure 75. Global Isoflurane Sales Market Forecast by Region (2026-2031)
Figure 76. Global Isoflurane Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Isoflurane Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Isoflurane Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Isoflurane Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Isoflurane Revenue Market Share Forecast by Application (2026-2031)